Multiple Sclerosis: Improvement of Visuoperceptive Functions by Picotesla Range Magnetic Fields DOI

Reuven Sandyk,

Robert P. Iacono

International Journal of Neuroscience, Journal Year: 1994, Volume and Issue: 74(1-4), P. 177 - 189

Published: Jan. 1, 1994

The occurrence of cognitive deficits in multiple sclerosis (MS) has been recognized since 1877 when Charcot first observed "enfeeblement memory" his patients. Recent studies employing standardized neuropsychological tests have confirmed the high incidence MS patients particularly those with a chronic progressive course disease. Visuoperceptive and visuomotor commonly occur are thought to reflect damage attentional systems due interruption by demyelinating plaques nerve conduction along ascending projections from brainstem reticular formation cortex. Impairment synaptic conductivity serotoninergic depletion (5-HT) may contribute emergence MS. present communication concerns 36 year old patient whom external application picoTesla range magnetic fields (MF) resulted rapid improvement symptoms including visuoperceptive functions as demonstrated on various drawing tasks. report confirms efficacy MF treatment demonstrates beneficial effects well.

Language: Английский

Melatonin: Buffering the Immune System DOI Open Access
Antonio Carrillo‐Vico, Patricia Judith Lardone, Nuria Álvarez‐Sánchez

et al.

International Journal of Molecular Sciences, Journal Year: 2013, Volume and Issue: 14(4), P. 8638 - 8683

Published: April 22, 2013

Melatonin modulates a wide range of physiological functions with pleiotropic effects on the immune system. Despite large number reports implicating melatonin as an immunomodulatory compound, it still remains unclear how regulates immunity. While some authors argue that is immunostimulant, many studies have also described anti-inflammatory properties. The data reviewed in this paper support idea buffer, acting stimulant under basal or immunosuppressive conditions compound presence exacerbated responses, such acute inflammation. clinical relevance multiple different conditions, infection, autoimmunity, vaccination and immunosenescence, reviewed.

Language: Английский

Citations

667

Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders DOI Open Access
Sheikh Bilal Ahmad, Aarif Ali, Midhat Bilal

et al.

Cellular and Molecular Neurobiology, Journal Year: 2023, Volume and Issue: 43(6), P. 2437 - 2458

Published: Feb. 8, 2023

Language: Английский

Citations

131

Seasonality and autoimmune diseases: The contribution of the four seasons to the mosaic of autoimmunity DOI
‬‬‬‬Abdulla Watad, Shir Azrielant, Nicola Luigi Bragazzi

et al.

Journal of Autoimmunity, Journal Year: 2017, Volume and Issue: 82, P. 13 - 30

Published: June 16, 2017

Language: Английский

Citations

155

Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: Implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin‐mediated osteoblastogenesis DOI

Sifat Maria,

Rebekah M. Samsonraj,

Fahima Munmun

et al.

Journal of Pineal Research, Journal Year: 2017, Volume and Issue: 64(3)

Published: Dec. 29, 2017

The Melatonin Osteoporosis Prevention Study (MOPS) demonstrated that nightly melatonin resulted in a time-dependent decrease equilibrium ratios of serum osteoclasts and osteoblasts perimenopausal women. This study examines mechanisms related to the using coculture models (transwell or layered) human mesenchymal stem cell (MSC) peripheral blood monocytes (PBMCs). Human MSC/PBMC cocultures exposed osteogenic (OS+) medium for 21 days induced osteoblast differentiation mineralization; however, only layered did inhibit osteoclastogenesis. effects were mediated through MT2 receptors, MEK1/2, MEK5. In but not transwell cocultures, increased OPG:RANKL by inhibiting RANKL, suggesting contact with during osteoblastogenesis inhibits RANKL secretion. modulated expression ERK1/2, ERK5, β1 integrin, GLUT4, IRβ was dependent upon type coculture; both cultures, RUNX2 decreased PPARγ expression, indicating role metabolic processes control vs adipogenic fates MSCs. Furthermore, also has osteoblast-inducing on adipose-derived vivo, one-year (15 mg/L) given neu female mice their drinking water pErk1/2, pErk5, Runx2, Opg Rankl levels bone consistent melatonin's already reported bone-enhancing effects. Finally, analysis daily logs from MOPS significant improvement mood perhaps sleep quality women receiving placebo. osteoblast-inducing, life suggest is safe effective loss therapy.

Language: Английский

Citations

135

Melatonin: A review of its potential functions and effects on neurological diseases DOI
Mehmet Günata, Hakan Parlakpınar, Ahmet Acet

et al.

Revue Neurologique, Journal Year: 2019, Volume and Issue: 176(3), P. 148 - 165

Published: Nov. 11, 2019

Language: Английский

Citations

133

Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis DOI

Lena Melamud,

Daniel Golan,

Rafael Luboshitzky

et al.

Journal of the Neurological Sciences, Journal Year: 2011, Volume and Issue: 314(1-2), P. 37 - 40

Published: Dec. 4, 2011

Language: Английский

Citations

110

The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis DOI
Daniel Golan, Elsebeth Staun-Ram,

Lea Glass‐Marmor

et al.

Brain Behavior and Immunity, Journal Year: 2013, Volume and Issue: 32, P. 180 - 185

Published: May 8, 2013

Language: Английский

Citations

59

Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches DOI Open Access
Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin

et al.

International Journal of Molecular Sciences, Journal Year: 2018, Volume and Issue: 19(4), P. 1212 - 1212

Published: April 16, 2018

Demyelination in multiple sclerosis (MS) cells is the site of several energy metabolic abnormalities driven by dysregulation between opposed interplay peroxisome proliferator-activated receptor γ (PPARγ) and WNT/β-catenin pathways. We focus our review on opposing interactions observed demyelinating processes MS canonical pathway PPARγ their reprogramming metabolism implications. associated with chronic inflammation, which itself release cytokines CD4+ Th17 cells, downregulation expression leading to upregulation pathway. Upregulation signaling induces activation glycolytic enzymes that modify behavior. Then, a large portion cytosolic pyruvate converted into lactate. This phenomenon called Warburg effect, despite availability oxygen. The effect shift an transfer production from mitochondrial oxidative phosphorylation aerobic glycolysis. Lactate correlated increased inducing dysfunction T axonal neuronal damage. In MS, decreases insulin sensitivity increases neuroinflammation. agonists inhibit differentiation then diminish cytokines. regulation circadian rhythms stimulate WNT initiate demyelination process. Moreover, contributes some key genes. Thus, interfere directly inhibiting could appear as promising treatments due these interactions.

Language: Английский

Citations

51

Anti‐inflammatory effects of melatonin in multiple sclerosis DOI
Mauricio Farez, Ismael Luis Calandri, Jorge Correale

et al.

BioEssays, Journal Year: 2016, Volume and Issue: 38(10), P. 1016 - 1026

Published: Aug. 26, 2016

Melatonin is a hormone with complex roles in the pathogenesis of autoimmune disorders. Over years, it has become clear that melatonin may exacerbate some conditions, whereas alleviates others such as multiple sclerosis. Multiple sclerosis an disorder characterized by dysregulated immune response directed against central nervous system. Indeed, balance between pathogenic CD4 + T cells secreting IFN‐γ (T H 1) or IL‐17 17); and FoxP3 regulatory IL‐10 type 1 (Tr1 cells) thought to play important role disease activity. Recent evidence suggests ameliorates controlling effector cells, suggesting melatonin‐triggered signaling pathways are potential targets for therapeutic intervention. Here, we review available data on effects processes relevant MS discuss its potential.

Language: Английский

Citations

44

The role of melatonin in Multiple Sclerosis DOI
Charalampos Skarlis, Maria Anagnostouli

Neurological Sciences, Journal Year: 2019, Volume and Issue: 41(4), P. 769 - 781

Published: Dec. 16, 2019

Language: Английский

Citations

40